author-photo

Peixin Dong

Hokkaido University

72

Papers

2291

Citations

Citation Trend

Filter By

Papers (48) Sort By

Journal Conference Others

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway

2021 Journal of Experimental & Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway.

2021 Cell & Bioscience
Show All
- Source
- Cite
- Save
Citations (1)
The investigation of the transient start-up behavior of natural draft dry cooling towers in dispatchable power plants

2021
- Peixin Dong
Show All
- Source
- Cite
- Save
Citations (0)
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1

2020 Cells
Show All
- Source
- Cite
- Save
Citations (18)
PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3

2020 Frontiers in Cell and Developmental Biology
Show All
- Source
- Cite
- Save
Citations (6)
Zinc regulates primary ovarian tumor growth and metastasis through the epithelial to mesenchymal transition.

2020 Free Radical Biology and Medicine
Show All
- Source
- Cite
- Save
Citations (2)
The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (19)
MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (9)
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

2019 Journal of Experimental & Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (62)
Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer (Oncogene, (2018), 37, 39, (5257-5268), 10.1038/s41388-018-0347-4)

2019 Oncogene
Show All
- Source
- Cite
- Save
Citations (2)